AAAAAA

   
Results: 1-25 |
Results: 25
Liposomal cancer chemotherapy: current clinical applications and future prospects
Authors: Harrington, KJ
Citation: Kj. Harrington, Liposomal cancer chemotherapy: current clinical applications and future prospects, EXPERT OP I, 10(6), 2001, pp. 1045-1061
Effective targeting of solid tumors in patients with locally advanced cancers by radiolabeled pegylated liposomes
Authors: Harrington, KJ Mohammadtaghi, S Uster, PS Glass, D Peters, AM Vile, RG Stewart, JSW
Citation: Kj. Harrington et al., Effective targeting of solid tumors in patients with locally advanced cancers by radiolabeled pegylated liposomes, CLIN CANC R, 7(2), 2001, pp. 243-254
The role of E-cadherin-catenin complex: More than an intercellular glue? (vol 7, pg 783, 2000)
Authors: Harrington, KJ
Citation: Kj. Harrington, The role of E-cadherin-catenin complex: More than an intercellular glue? (vol 7, pg 783, 2000), ANN SURG O, 8(2), 2001, pp. 186-186
Phase II study of pegylated liposomal doxorubicin (Caelyx (TM)) as induction chemotherapy for patients with squamous cell cancer of the head and neck
Authors: Harrington, KJ Lewanski, C Northcote, AD Whittaker, J Peters, AM Vile, RG Stewart, JSW
Citation: Kj. Harrington et al., Phase II study of pegylated liposomal doxorubicin (Caelyx (TM)) as induction chemotherapy for patients with squamous cell cancer of the head and neck, EUR J CANC, 37(16), 2001, pp. 2015-2022
Phase I-II study of pegylated liposomal cisplatin (SPI-077 (TM)) in patients with inoperable head and neck cancer
Authors: Harrington, KJ Lewanski, CR Northcote, AD Whittaker, J Wellbank, H Vile, RG Peters, AM Stewart, JSW
Citation: Kj. Harrington et al., Phase I-II study of pegylated liposomal cisplatin (SPI-077 (TM)) in patients with inoperable head and neck cancer, ANN ONCOL, 12(4), 2001, pp. 493-496
The effect of irradiation on the biodistribution of radiolabeled pegylatedliposomes
Authors: Harrington, KJ Rowlinson-Busza, G Syrigos, KN Uster, PS Vile, RG Peters, AM Stewart, JSW
Citation: Kj. Harrington et al., The effect of irradiation on the biodistribution of radiolabeled pegylatedliposomes, INT J RAD O, 50(3), 2001, pp. 809-820
Single-fraction irradiation has no effect on uptake of radiolabeled pegylated liposomes in a tumor xenograft model
Authors: Harrington, KJ Rowlinson-Busza, G Uster, PS Vile, RG Peters, AM Stewart, JSW
Citation: Kj. Harrington et al., Single-fraction irradiation has no effect on uptake of radiolabeled pegylated liposomes in a tumor xenograft model, INT J RAD O, 49(4), 2001, pp. 1141-1148
The development of monoclonal antibody therapy in leukemias
Authors: Syrigos, KN Pliarchopoulou, K Harrington, KJ
Citation: Kn. Syrigos et al., The development of monoclonal antibody therapy in leukemias, HYBRIDOMA, 20(3), 2001, pp. 145-148
Balanced branching in transcription termination
Authors: Harrington, KJ Laughlin, RB Liang, S
Citation: Kj. Harrington et al., Balanced branching in transcription termination, P NAS US, 98(9), 2001, pp. 5019-5024
Gene therapy for prostate cancer: Current status and future prospects
Authors: Harrington, KJ Spitzweg, C Bateman, AR Morris, JC Vile, RG
Citation: Kj. Harrington et al., Gene therapy for prostate cancer: Current status and future prospects, J UROL, 166(4), 2001, pp. 1220-1233
The sodium iodide symporter and its potential role in cancer therapy
Authors: Spitzweg, C Harrington, KJ Pinke, LA Vile, RG Morris, JC
Citation: C. Spitzweg et al., The sodium iodide symporter and its potential role in cancer therapy, J CLIN END, 86(7), 2001, pp. 3327-3335
Slow release sources of acetylene to inhibit nitrification in soil
Authors: Freney, JR Randall, PJ Smith, JWB Hodgkin, J Harrington, KJ Morton, TC
Citation: Jr. Freney et al., Slow release sources of acetylene to inhibit nitrification in soil, NUTR CYCL A, 56(3), 2000, pp. 241-251
Cancer gene therapy: developments to 2000
Authors: Bateman, AR Harrington, KJ Melcher, AA Vile, RG
Citation: Ar. Bateman et al., Cancer gene therapy: developments to 2000, EXPERT OP I, 9(12), 2000, pp. 2799-2813
Pegylated liposomes have potential as vehicles for intratumoral and subcutaneous drug delivery
Authors: Harrington, KJ Rowlinson-Busza, G Syrigos, KN Uster, PS Vile, RG Stewart, JSW
Citation: Kj. Harrington et al., Pegylated liposomes have potential as vehicles for intratumoral and subcutaneous drug delivery, CLIN CANC R, 6(6), 2000, pp. 2528-2537
Pegylated liposome-encapsulated doxorubicin and cisplatin enhance the effect of radiotherapy in a tumor xenograft model
Authors: Harrington, KJ Rowlinson-Busza, G Syrigos, KN Vile, RG Uster, PS Peters, AM Stewart, JSW
Citation: Kj. Harrington et al., Pegylated liposome-encapsulated doxorubicin and cisplatin enhance the effect of radiotherapy in a tumor xenograft model, CLIN CANC R, 6(12), 2000, pp. 4939-4949
Liposomes as vehicles for targeted therapy of cancer. Part 1: Preclinical development
Authors: Harrington, KJ Lewanski, CR Stewart, JSW
Citation: Kj. Harrington et al., Liposomes as vehicles for targeted therapy of cancer. Part 1: Preclinical development, CL ONCOL-UK, 12(1), 2000, pp. 2-15
Liposomes as vehicles for targeted therapy of cancer. Part 2: Clinical development
Authors: Harrington, KJ Lewanski, CR Stewart, JSW
Citation: Kj. Harrington et al., Liposomes as vehicles for targeted therapy of cancer. Part 2: Clinical development, CL ONCOL-UK, 12(1), 2000, pp. 16-24
Pegylated liposome-encapsulated doxorubicin and cisplatin in the treatmentof head and neck xenograft tumours
Authors: Harrington, KJ Rowlinson-Busza, G Uster, PS Stewart, JS
Citation: Kj. Harrington et al., Pegylated liposome-encapsulated doxorubicin and cisplatin in the treatmentof head and neck xenograft tumours, CANC CHEMOT, 46(1), 2000, pp. 10-18
Transcriptional control: An essential component of cancer gene therapy strategies?
Authors: Harrington, KJ Linardakis, E Vile, RG
Citation: Kj. Harrington et al., Transcriptional control: An essential component of cancer gene therapy strategies?, ADV DRUG DE, 44(2-3), 2000, pp. 167-184
Influence of tumour size on uptake of In-111-DTPA-labelled pegylated liposomes in a human tumour xenograft model
Authors: Harrington, KJ Rowlinson-Busza, G Syrigos, KN Abra, RM Uster, PS Peters, AM Stewart, JSW
Citation: Kj. Harrington et al., Influence of tumour size on uptake of In-111-DTPA-labelled pegylated liposomes in a human tumour xenograft model, BR J CANC, 83(5), 2000, pp. 684-688
Biodistribution and pharmacokinetics of In-111-DTPA-labelled pegylated liposomes in a human tumour xenograft model: implications for novel targeting strategies
Authors: Harrington, KJ Rowlinson-Busza, G Syrigos, KN Uster, PS Abra, RM Stewart, JSW
Citation: Kj. Harrington et al., Biodistribution and pharmacokinetics of In-111-DTPA-labelled pegylated liposomes in a human tumour xenograft model: implications for novel targeting strategies, BR J CANC, 83(2), 2000, pp. 232-238
Role of adhesion molecules in bladder cancer: An important part of the jigsaw
Authors: Syrigos, KN Harrington, KJ Pignatelli, M
Citation: Kn. Syrigos et al., Role of adhesion molecules in bladder cancer: An important part of the jigsaw, UROLOGY, 53(2), 1999, pp. 428-434
The role of adhesion molecules in biology of bladder cancer
Authors: Syrigos, KN Harrington, KJ Pignatelli, M
Citation: Kn. Syrigos et al., The role of adhesion molecules in biology of bladder cancer, OX MED PUBL, 1999, pp. 157-166
Radiotherapy in the management of muscle-invasive bladder cancer
Authors: Harrington, KJ Sikora, K
Citation: Kj. Harrington et K. Sikora, Radiotherapy in the management of muscle-invasive bladder cancer, OX MED PUBL, 1999, pp. 261-297
Palliative care for patients with bladder cancer
Authors: Harrington, KJ Syrigos, KN
Citation: Kj. Harrington et Kn. Syrigos, Palliative care for patients with bladder cancer, OX MED PUBL, 1999, pp. 423-448
Risultati: 1-25 |